A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine | MicrobiomeTrials← Back to trialsNCT07609914
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
RecruitingPHASE4INTERVENTIONAL
Trial Details
Start: 2026-05-28Est. Completion: 2028-05-15
Enrollment target: 400 participants Locations- Hope Clinical Research, Canoga Park, California, United States
- Neurology Offices of South Florida, Boca Raton, Florida, United States
- Clinical Neuroscience Solutions, Orlando, Florida, United States
Other microbiome trials you might be interested in
Temporomandibular Disorder
Temporomandibular disorders (TMD) encompass a group of conditions involving the masticatory muscles, temporomandibular j…
Ridgeland, United StatesEst. completion Jan 1, 2027
Menstrual Migraine
The purpose of this study is to evaluate the efficacy and safety of rimegepant when administered during the peri-menstru…
Phoenix, United StatesEst. completion Nov 29, 2026